Pharmafile Logo
Pharmafocus logo
Advanced Search

Tasigna more effective than Glivec, says Novartis

June 21, 2010
Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …

News

Depomed pulls diabetes drug Glumetza

June 21, 2010
Manufacturing and Production Depomed, Glumetza, manufacturing compliance

Another pharmaceutical manufacturer has been forced to recall products because of contamination caused by a chemical used to treat wooden …

News

AMRI buys Hyaluron to enter prefilled syringes market

June 21, 2010
Manufacturing and Production AMRI, Hyaluron

Contract manufacturing organisation Albany Molecular Research Inc (AMRI) has added to its capabilities with the $27 million purchase of US …

News
Ecteinascidia turbinata

NICE rejects Yondelis in ovarian cancer

June 21, 2010
Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer

New cancer treatment Yondelis has been rejected by NICE in a preliminary ruling on its use in relapsed ovarian cancer. …

News

Avastin will remain gold standard for lung cancer to 2018

June 20, 2010
Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin

 Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …

News
NHS Football Fitness

Digital Pharma: Byte-sized roundup

June 18, 2010
Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …

News

Fishawack acquires Alpha-Plus

June 18, 2010
Medical Communications fishawack

Fishawack has acquired fellow medical communications agency Alpha-Plus as it continues its ‘buy and build’ expansion plan. This has recently …

News

Contract research news in brief

June 18, 2010
Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research

Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …

News

Prolia gets early thumbs up from NICE

June 18, 2010
Sales and Marketing Amgen, NICE, Prolia

Amgen’s new treatment to prevent bone fractures caused by osteoporosis has been given preliminary approval from the UK’s cost effectiveness …

News

J&J expands recall of ‘musty’ products

June 18, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance

Johnson & Johnson’s manufacturing troubles continues to build with yet another recall announced this week, this time for additional lots …

News

MedImmune Ventures appoints Ron Laufer

June 18, 2010
Research and Development AstraZeneca, MedImmune, appointment, research and development

Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …

Appointment

Bayer signs cancer stem cell research deal

June 18, 2010
Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells

Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …

News

Kemwell expands Swedish production unit

June 17, 2010
Manufacturing and Production Kemwell, contract manufacturing

Indian contract manufacturer Kemwell has doubled production capacity at its facility in Sweden in order to help it serve customers …

News

Trials of cancer vaccine Stimuvax can resume

June 17, 2010
Research and Development Merck Serono, Stimuvax, cancer vaccine, vaccines

Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …

News

UCB’s new lupus treatment promising

June 17, 2010
Research and Development Benlysta, Lupus, UCB, epratuzumab

A new monoclonal antibody treatment for lupus has shown promise in phase II trials, according to UCB. The biopharmaceutical company …

News

PAN makes creative appointments

June 17, 2010
Medical Communications Pan, appointment, medical communications

UK agency PAN Advertising has made two new appointments to its creative department – Gareth Goh as copywriter and Adam Wood as …

Appointment

ABPI appoints former AZ innovation head

June 17, 2010
Research and Development, Sales and Marketing ABPI, appointment, research and development, sales and marketing

UK industry association the ABPI has appointed Carol Blount as its new head of commercial affairs. Carol has more than …

Appointment
Tom McKillop and Fred Goodwin

Reinventing Management

June 17, 2010
Research and Development, Sales and Marketing management

The investment banking industry officially ceased to exist on September 21, 2008. That was the day the last two remaining …

Feature
Tarceva

NICE rejects Tarceva maintenance treatment

June 17, 2010
Sales and Marketing NICE, NSCLC, Roche, Tarceva, lung cancer

Roche’s Tarceva should not be used in lung cancer patients who have already been treated and whose disease remains stable, …

News
Blog footer

Digital Pharma: Amgen’s online village

June 16, 2010
Medical Communications Amgen, ITP, community, disease awareness campaigns

Amgen has launched an online community for European healthcare professionals, patients and carers affected by autoimmune disease immune thrombycytopenia. Styled …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026